Decheng Capital Management II (Cayman), LLC — SEC Form 4 filings

SEC reporting owner CIK 2089149. 5 Form 4 filings on record with FilingPulse; latest filed 2025-10-20.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2025-10-02 to 2025-10-20. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
BeyondSpring Inc. (BYSI)10% owner514 legs · 326,868 sh · $561,324

Form 4 filings — Decheng Capital Management II (Cayman), LLC

FiledFormIssuerReported transactionsSource
2025-10-204BeyondSpring Inc. (BYSI)
jointly with Decheng Capital China Life Sciences USD Fund III, L.P., Decheng Capital Management III (Cayman), LLC, Decheng Capital China Life Sciences USD Fund II, L.P., Decheng Capital Global Healthcare Fund (Master), LP, Decheng Capital Global Healthcare GP, LLC, Cui Xiangmin
Sale (S): 85,798 @ $1.72 · Sale (S): 45,513 @ $1.76EDGAR
2025-10-154BeyondSpring Inc. (BYSI)
jointly with Decheng Capital China Life Sciences USD Fund III, L.P., Decheng Capital Management III (Cayman), LLC, Decheng Capital China Life Sciences USD Fund II, L.P., Decheng Capital Global Healthcare Fund (Master), LP, Decheng Capital Global Healthcare GP, LLC, Cui Xiangmin
Sale (S): 107,361 @ $1.70 · Sale (S): 28,495 @ $1.65 · Sale (S): 17,960 @ $1.65EDGAR
2025-10-104BeyondSpring Inc. (BYSI)
jointly with Decheng Capital China Life Sciences USD Fund III, L.P., Decheng Capital Management III (Cayman), LLC, Decheng Capital China Life Sciences USD Fund II, L.P., Decheng Capital Global Healthcare Fund (Master), LP, Decheng Capital Global Healthcare GP, LLC, Cui Xiangmin
Sale (S): 7,507 @ $1.77 · Sale (S): 3,979 @ $1.81 · Sale (S): 2,390 @ $1.77EDGAR
2025-10-074BeyondSpring Inc. (BYSI)
jointly with Decheng Capital China Life Sciences USD Fund III, L.P., Decheng Capital Management III (Cayman), LLC, Decheng Capital China Life Sciences USD Fund II, L.P., Decheng Capital Global Healthcare Fund (Master), LP, Decheng Capital Global Healthcare GP, LLC, Cui Xiangmin
Sale (S): 600 @ $1.76 · Sale (S): 17,500 @ $1.78 · Sale (S): 2,100 @ $1.79EDGAR
2025-10-024BeyondSpring Inc. (BYSI)
jointly with Decheng Capital China Life Sciences USD Fund III, L.P., Decheng Capital Management III (Cayman), LLC, Decheng Capital China Life Sciences USD Fund II, L.P., Decheng Capital Global Healthcare Fund (Master), LP, Decheng Capital Global Healthcare GP, LLC, Cui Xiangmin
Sale (S): 4,464 @ $1.81 · Sale (S): 2,601 @ $1.80 · Sale (S): 600 @ $1.73EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2089149 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →